NYSEARCA:BBC Virtus LifeSci Biotech Clinical Trials ETF (BBC) Price, Holdings, & News $29.76 +0.37 (+1.26%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$29.74▼$30.0550-Day Range$24.56▼$30.2152-Week Range$16.88▼$31.99Volume1,870 shsAverage Volume3,602 shsMarket Capitalization$11.90 millionAssets Under Management$11.73 millionDividend Yield0.30%Net Expense Ratio0.79% Stock AnalysisStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Get Virtus LifeSci Biotech Clinical Trials ETF alerts: Email Address About Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC)The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.Read More BBC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BBC ETF News HeadlinesJuly 23, 2024 | americanbankingnews.comVirtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Trading 3.1% Higher July 20, 2024 | lse.co.ukVirtus Lifesci Biotech Products Etf Share ChatJuly 27, 2024 | Paradigm Press (Ad)Musk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840.July 20, 2024 | lse.co.ukVirtus Lifesci Biotech Clinical Trials Etf Share ChatMay 22, 2024 | bbc.comDrama at Trump trial as judge reprimands witness and clears courtSeptember 26, 2023 | bbc.co.ukSkipton hotel boss cleared as death crash trial collapsesJuly 30, 2023 | bbc.co.ukPuberty blockers to be given only in clinical researchJune 29, 2023 | ft.comBiotech begins human trials of drug designed by artificial intelligenceJuly 27, 2024 | Paradigm Press (Ad)Musk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840.May 8, 2023 | finance.yahoo.com4 Best-Performing ETF Areas of Last WeekSee More Headlines Receive BBC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVirtus Fund NameVirtus LifeSci Biotech Clinical Trials ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BBC Inception Date12/16/2014 Fund ManagerMatthew B. Brown, Seth Kadushin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkLifeSci Biotechnology Clinical Trials Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings124 Fund Statistics Assets Under Management$11.73 million Average Daily Volume$3,101.90 Discount/Premium0.07% Administrator, Advisor and Custodian AdministratorVirtus ETF Solutions, LLC AdvisorVirtus ETF Advisers LLC CustodianThe Bank of New York Mellon Corporation DistributorETF Distributors LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest2,700 shs Miscellaneous Outstanding Shares400,004Beta1.22 Creation Unit50,000 Creation Fee$500.00 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Ad Weiss RatingsNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. Virtus LifeSci Biotech Clinical Trials ETF ExpensesTypeBBCHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.79%0.56%0.54%0.51%0.51%Other Expenses0.00%0.33%0.50%0.59%0.54%Total Expense0.79%0.70%0.70%0.74%0.71%Fee Waiver0.00%-0.45%-0.54%-0.69%-0.59%Net Expense0.79%0.61%0.60%0.58%0.58% Virtus LifeSci Biotech Clinical Trials ETF (BBC) Holdings & ExposureTop 10 BBC HoldingsBny Mellon Cash Reserve UsdHolding Weight: 1.97%Morphic(NASDAQ:MORF)Holding Weight: 1.66%Longboard Pharmaceuticals(NASDAQ:LBPH)Holding Weight: 1.47%Acelyrin(NASDAQ:SLRN)Holding Weight: 1.22%uniQure(NASDAQ:QURE)Holding Weight: 1.20%AnaptysBio(NASDAQ:ANAB)Holding Weight: 1.13%Praxis Precision Medicines(NASDAQ:PRAX)Holding Weight: 1.12%Erasca(NASDAQ:ERAS)Holding Weight: 1.10%IGM Biosciences(NASDAQ:IGMS)Holding Weight: 1.10%ORIC Pharmaceuticals(NASDAQ:ORIC)Holding Weight: 1.08%BBC Sector ExposureBBC Industry ExposureFull Holdings Details Similar ETFsDirexion Daily Pharmaceutical & Medical Bull 3X SharesNYSEARCA:PILLJPMorgan Healthcare Leaders ETFNASDAQ:JDOCHarbor Health Care ETFNYSEARCA:MEDIPrincipal Healthcare Innovators ETFNASDAQ:BTECHorizon Kinetics Medical ETFNASDAQ:MEDX BBC ETF - Frequently Asked Questions How have BBC shares performed this year? Virtus LifeSci Biotech Clinical Trials ETF's stock was trading at $24.45 on January 1st, 2024. Since then, BBC stock has increased by 21.7% and is now trading at $29.7608. View the best growth stocks for 2024 here. How do I buy shares of Virtus LifeSci Biotech Clinical Trials ETF? Shares of BBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Virtus LifeSci Biotech Clinical Trials ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Virtus LifeSci Biotech Clinical Trials ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), Simon Property Group (SPG) and Cisco Systems (CSCO). This page (NYSEARCA:BBC) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
